Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cohort Profile: The European Male Ageing Study.

Lee, David M ; Pye, Stephen R ; Tajar, Abdelouahid ; O'Neill, Terence W ; Finn, Joseph D ; Boonen, Steven ; Bartfai, Gyorgy ; Casanueva, Felipe F ; Forti, Gianni and Giwercman, Aleksander LU , et al. (2013) In International Journal of Epidemiology 42(2). p.391-401
Abstract
The European Male Ageing Study (EMAS) was designed to examine the hypothesis that inter-individual and regional variability in symptomatic dysfunctions, alterations in body composition and health outcomes in ageing men can be explained by different rates of decline in anabolic hormones, the most important of which being testosterone. Between 2003 and 2005, 3369 community-dwelling men, aged between 40 and 79 years, were recruited from population-based registers in eight European centres to participate in the baseline survey, with follow-up investigations performed a median of 4.3 years later. Largely, identical questionnaire instruments and clinical investigations were used in both phases to capture contemporaneous data on general health... (More)
The European Male Ageing Study (EMAS) was designed to examine the hypothesis that inter-individual and regional variability in symptomatic dysfunctions, alterations in body composition and health outcomes in ageing men can be explained by different rates of decline in anabolic hormones, the most important of which being testosterone. Between 2003 and 2005, 3369 community-dwelling men, aged between 40 and 79 years, were recruited from population-based registers in eight European centres to participate in the baseline survey, with follow-up investigations performed a median of 4.3 years later. Largely, identical questionnaire instruments and clinical investigations were used in both phases to capture contemporaneous data on general health (including cardiovascular diseases and chronic conditions), physical and cognitive functioning, mental health, sexual function, quality of life, bone health, chronic pain, disease biomarkers, hormones (sex hormones and metabolic hormones) and genetic polymorphisms. EMAS actively encourages new collaborations, data sharing for validation studies and participation in genetic study consortia. Potential collaborators should contact the principal investigator (F.C.W.W.) in the first instance. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
International Journal of Epidemiology
volume
42
issue
2
pages
391 - 401
publisher
Oxford University Press
external identifiers
  • wos:000317627800009
  • pmid:22314965
  • scopus:84877033371
  • pmid:22314965
ISSN
1464-3685
DOI
10.1093/ije/dyr234
language
English
LU publication?
yes
id
72bb10d3-5ebc-46f2-bab6-7c2656ea7484 (old id 2367162)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/22314965?dopt=Abstract
date added to LUP
2016-04-01 10:19:49
date last changed
2025-04-04 15:07:48
@article{72bb10d3-5ebc-46f2-bab6-7c2656ea7484,
  abstract     = {{The European Male Ageing Study (EMAS) was designed to examine the hypothesis that inter-individual and regional variability in symptomatic dysfunctions, alterations in body composition and health outcomes in ageing men can be explained by different rates of decline in anabolic hormones, the most important of which being testosterone. Between 2003 and 2005, 3369 community-dwelling men, aged between 40 and 79 years, were recruited from population-based registers in eight European centres to participate in the baseline survey, with follow-up investigations performed a median of 4.3 years later. Largely, identical questionnaire instruments and clinical investigations were used in both phases to capture contemporaneous data on general health (including cardiovascular diseases and chronic conditions), physical and cognitive functioning, mental health, sexual function, quality of life, bone health, chronic pain, disease biomarkers, hormones (sex hormones and metabolic hormones) and genetic polymorphisms. EMAS actively encourages new collaborations, data sharing for validation studies and participation in genetic study consortia. Potential collaborators should contact the principal investigator (F.C.W.W.) in the first instance.}},
  author       = {{Lee, David M and Pye, Stephen R and Tajar, Abdelouahid and O'Neill, Terence W and Finn, Joseph D and Boonen, Steven and Bartfai, Gyorgy and Casanueva, Felipe F and Forti, Gianni and Giwercman, Aleksander and Han, Thang S and Huhtaniemi, Ilpo T and Kula, Krzysztof and Lean, Michael Ej and Pendleton, Neil and Punab, Margus and Silman, Alan J and Vanderschueren, Dirk and Wu, Frederick Cw}},
  issn         = {{1464-3685}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{391--401}},
  publisher    = {{Oxford University Press}},
  series       = {{International Journal of Epidemiology}},
  title        = {{Cohort Profile: The European Male Ageing Study.}},
  url          = {{http://dx.doi.org/10.1093/ije/dyr234}},
  doi          = {{10.1093/ije/dyr234}},
  volume       = {{42}},
  year         = {{2013}},
}